文献速递妇科

腔内肿瘤细胞与子宫内膜癌分期标准的预后准确性:一项多机构研究

Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study.
PubMed 文献 · Gynecol Oncol · 2023-10-19

本研究为回顾性队列研究,纳入2007至2012年五家学术医院诊断的1303例子宫内膜癌患者,由病理学家判定输卵管腔内肿瘤细胞(ILTCs)的有无及位置。总体人群中ILTCs与复发时间(HR=0.95,95%CI=0.69-1.32)和总生存(HR=0.97,95%CI=0.72-1.31)无独立关联;但在805例I期患者中,ILTCs与更差的复发时间(HR=2.31,95%CI=1.06-5.05)和总生存(HR=2.16,95%CI=1.14-4.11)独立相关。将ILTCs阳性早期病例升级分期并未提高模型区分度。

要点

  • 总体人群中ILTCs与复发时间和总生存无独立关联。
  • I期患者中ILTCs与更差复发时间(HR=2.31)和总生存(HR=2.16)独立相关。
  • 将ILTCs阳性早期病例升级分期未提高模型区分度。

核心结论

  • 数据不支持修订子宫内膜癌分期指南以纳入ILTCs。
  • I期病例中ILTCs与生存降低的关联提示该肿瘤特征对部分子宫内膜癌患者具有临床相关性。

研究设计与样本

  • 回顾性队列研究,纳入2007至2012年五家学术医院诊断的子宫内膜癌女性,共1303例。
  • 由病理学家基于输卵管苏木精-伊红染色切片复核判定ILTCs有无(无 vs. 有)及位置(管腔内游离 vs. 附着于上皮表面)。

主要发现

  • 总体人群(N=1303)中ILTCs与复发时间无独立关联(HR=0.95,95%CI=0.69-1.32),与总生存无独立关联(HR=0.97,95%CI=0.72-1.31)。
  • 805例I期患者中,ILTCs与更差复发时间独立相关(HR=2.31,95%CI=1.06-5.05),与更差总生存独立相关(HR=2.16,95%CI=1.14-4.11)。
  • 将ILTCs阳性的早期病例升级分期未提高模型区分度。

临床怎么用

  • 作者认为数据不支持修订子宫内膜癌分期指南以纳入ILTCs,但I期病例中ILTCs与生存降低的关联提示该特征对部分患者具有临床相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endometrial cancer stage is a strong prognostic factor; however, the current stage classification does not incorporate transtubal spread as determined by intraluminal tumor cells (ILTCs). We examined relationships between ILTCs and survival outcomes according to histological subtype and stage and examined whether identification of ILTCs improves prognostic accuracy of endometrial cancer staging. METHODS: We conducted a retrospective cohort study of women diagnosed with endometrial cancer at five academic hospitals between 2007 and 2012. Pathologists determined ILTC presence (no vs. yes) and location (free in lumen vs. attached to epithelial surface) based on pathology review of hematoxylin and eosin-stained sections of fallopian tubes. Associations between ILTCs with time to recurrence (TTR) and overall survival (OS) were examined with Cox proportional hazards models adjusted for other prognostic factors. Model discrimination metrics were used to assess the addition of ILTCs to stage for prediction of 5-year TTR and OS. RESULTS: In the overall study population (N = 1303), ILTCs were not independently associated with TTR (HR = 0.95, 95% CI = 0.69-1.32) or OS (HR = 0.97, 95% CI = 0.72-1.31). Among 805 women with stage I disease, ILTCs were independently associated with worse TTR (HR = 2.31, 95% CI = 1.06-5.05) and OS (HR = 2.16, 95% CI = 1.14-4.11). Upstaging early-stage cases with ILTCs present did not increase model discrimination. CONCLUSION: While our data do not suggest that endometrial cancer staging guidelines should be revised to include ILTCs, associations between ILTCs and reduced survival observed among stage I cases suggest this tumor feature holds clinical relevance for subgroups of endometrial cancer patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Felix AS, Sinnott JA, Cohn DE, et al. Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study. Gynecol Oncol. 2023. PMID: 37862792. doi:10.1016/j.ygyno.2023.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。